Loading...

APC anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_APC_122007
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 APC
  • BM8_APC_122007
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
123115 25 µg 50 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123116 100 µg 143 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80, also known as EMR1 or Ly71, is a 160 kD glycoprotein of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80 has been widely used as a murine macrophage marker. It is expressed on a majority of tissue macrophages, including macrophages in the lung, gut, peritoneal cavity, thymus, and red pulp of the spleen, Kupffer cells, Langerhans cells, microglia, and certain dendritic cells. It is not expressed on macrophages located in the T cell areas of the spleen, lymph node, or Peyer's patch. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for the induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The F4/80 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  2. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  3. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  4. Nguyen T, et al. 2021. STAR Protoc. 2:101004. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  7. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  8. Yang D, et al. 2022. Cell. 185:1905. PubMed
  9. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  10. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  11. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  12. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  13. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  14. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  15. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  16. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  17. Tian WJ, et al. 2021. Clin Exp Pharmacol Physiol. 48:902. PubMed
  18. Fang C, et al. 2022. J Pathol. 256:310. PubMed
  19. Ozga AJ, et al. 2022. Immunity. 55:82. PubMed
  20. Liang X, et al. 2022. Cancer Commun (Lond). 42:205. PubMed
  21. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  22. Chen J, et al. 2022. Adv Sci (Weinh). 9:e2200668. PubMed
  23. Sipilä K, et al. 2022. Dev Cell. 57:1453. PubMed
  24. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  25. Aghayev T, et al. 2022. Cancer Discov. 12:1960. PubMed
  26. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  27. Schaue D, et al. 2022. Antioxidants (Basel). 11: . PubMed
  28. Roy IM, et al. 2022. iScience. 25:105171. PubMed
  29. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  30. Yoo HJ, et al. 2022. Cell Rep. 41:111598. PubMed
  31. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  32. Miao Y, et al. 2022. Front Pharmacol. 13:1032741. PubMed
  33. Kuo CS, et al. 2022. Elife. 11: . PubMed
  34. Lee DE, et al. 2022. Nat Commun. 13:7613. PubMed
  35. Wang R, et al. 2023. Nat Biomed Eng. 7:38. PubMed
  36. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  37. Fan R, et al. 2023. J Immunother Cancer. 11: . PubMed
  38. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  39. Fontana MF, et al. 2023. Elife. 12: . PubMed
  40. Kulkarni R, et al. 2023. Life Sci Alliance. 6: . PubMed
  41. Slusarczyk P, et al. 2023. Elife. 12: . PubMed
  42. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  43. Tunali G, et al. 2023. J Clin Invest. :. PubMed
  44. Li S, et al. 2023. Exp Mol Med. 55:457. PubMed
  45. Li FJ, et al. 2022. Am J Physiol Lung Cell Mol Physiol. 322:L593. PubMed
  46. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  47. Fernández-García V, et al. 2022. Biomed Pharmacother. 148:112769. PubMed
  48. Mise Y, et al. 2022. Carcinogenesis. 43:647. PubMed
  49. Quattrocelli M, et al. 2022. J Exp Med. 219:. PubMed
  50. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  51. Li T, et al. 2022. J Leukoc Biol. 112:845. PubMed
  52. Lin J, et al. 2022. Adv Sci (Weinh). 9:e2202633. PubMed
  53. Awida Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  54. Czimmerer Z, et al. 2022. Immunity. 55:2006. PubMed
  55. Amodio V, et al. 2023. Cancer Cell. 41:196. PubMed
  56. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  57. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  58. Liu PS, et al. 2023. Nat Immunol. 24:452. PubMed
  59. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  60. Liu N, et al. 2023. Cell Death Dis. 14:170. PubMed
  61. Spitzer D, et al. 2023. Nat Protoc. 18:1510. PubMed
  62. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  63. Tan J, et al. 2023. Acta Pharm Sin B. 13:632. PubMed
  64. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  65. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  66. Do-Thi VA, et al. 2023. Cancer Res Commun. 3:80. PubMed
  67. He XY, et al. 2023. Nat Commun. 14:2253. PubMed
  68. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  69. He Q, et al. 2023. Parasit Vectors. 16:139. PubMed
  70. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  71. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  72. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  73. He Y, et al. 2023. Biomolecules. 13:. PubMed
  74. Wang C, et al. 2023. Int J Oral Sci. 15:19. PubMed
  75. Wang K, et al. 2023. Nat Commun. 14:2950. PubMed
  76. Song S, et al. 2023. Bioact Mater. 28:358. PubMed
  77. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  78. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  79. He F, et al. 2021. J Exp Med. 218:. PubMed
  80. Platt DJ, et al. 2021. Cell Reports. 35(6):109113. PubMed
  81. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  82. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  83. Bousset L, et al. 2020. PLoS Biol. 18:e3000948. PubMed
  84. Yu J, et al. 2020. Sci Rep. 10:21360. PubMed
  85. Yan X, et al. 2022. Commun Biol. 5:320. PubMed
  86. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  87. He R, et al. 2021. J Immunol. 206:2353. PubMed
  88. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  89. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  90. Sharma-Chawla N, et al. 2016. Infect Immun . . PubMed
  91. Emal D, et al. 2016. J Am Soc Nephrol. 10.1681/ASN.2016030255. PubMed
  92. Dale M, et al. 2016. J Immunol. 196: 4536 - 4543. PubMed
  93. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  94. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  95. Bieren J, et al. 2015. J Immunol. 194:1154. PubMed
  96. Prantner D, et al. 2009. Infect Immun. 77:5334. PubMed
  97. Cullis J, et al. 2017. Cancer Immunol Res. 5:182. PubMed
  98. Kim SE, et al. 2019. Nutrients. 11. PubMed
  99. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  100. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  101. Dong L, et al. 2021. Cancer Cell. . PubMed
  102. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  103. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  104. Sjöstrand M, et al. 2013. J Immunol. 191:3753. PubMed
  105. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  106. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  107. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  108. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  109. Stubelius A, et al. 2012. Immunobiology. 217:751. PubMed
  110. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  111. Yates C, et al. 2017. Stem Cell Res Ther. 10.1186/s13287-017-0644-9. PubMed
  112. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  113. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  114. Liang F, et al. 2021. Front Immunol. 12:658715. PubMed
  115. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  116. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  117. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  118. Xu Y, et al. 2020. Mol Ther. 28:202. PubMed
  119. Mia MM, et al. 2020. PLoS Biol. 18:e3000941. PubMed
  120. Han J, et al. 2022. FEBS J. 289:417. PubMed
  121. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  122. Xing J, et al. 2016. Nat Immunol. 17:1373-1380. PubMed
  123. Zhu J, et al. 2016. Sci Rep. 6:27136. PubMed
  124. Sun P, et al. 2015. J Hepatol. . PubMed
  125. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  126. Gritsina G, et al. 2015. Mol Cancer Ther. 14:1035. PubMed
  127. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  128. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  129. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  130. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  131. Tajfirouz D, et al. 2017. Virology. 10.1016/j.virol.2017.02.022. PubMed
  132. Krivanek J, et al. 2020. Nat Commun. 3.802777778. PubMed
  133. Brestoff JR, et al. 2021. Cell Metab. 33:270. PubMed
  134. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  135. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  136. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  137. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  138. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  139. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  140. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  141. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  142. Qi F, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.05.008. PubMed
  143. Stefan K, et al. 2017. PLoS One. . 10.1371/journal.pone.0188600. PubMed
  144. Sinha M, et al. 2018. Nat Commun. 9:936. PubMed
  145. Grohmann M et al. 2018. Cell. 175(5):1289-1306 . PubMed
  146. Kosack L, et al. 2017. Sci Rep. 7:11289. PubMed
  147. Christopher S Garris et al. 2018. Immunity. 49(6):1148-1161 . PubMed
  148. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  149. Ling X, et al. 2021. ACS Nano. 15:765. PubMed
  150. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  151. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  152. Jiao H, et al. 2021. Cell. 184(11):2896-2910.e13. PubMed
  153. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  154. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  155. Kosaric N, et al. 2020. Mol Ther. 28:2007. PubMed
  156. Shang Y, et al. 2016. Nat Immunol. 10.1038/ni.3486. PubMed
  157. Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed
  158. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  159. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  160. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  161. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  162. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  163. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  164. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  165. Sun L, et al. 2020. J Immunol. 2177:204. PubMed
  166. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  167. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  168. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  169. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  170. Helmi N, et al. 2015. J Infect Dis. 211:1677. PubMed
  171. Tsoyi K, et al. 2015. J Leukoc Biol. 97:171. PubMed
  172. Ma Y, et al. 2015. Cardiovasc Res. 106:421. PubMed
  173. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  174. Giri J, et al. 2020. Cell Rep. 30:1923. PubMed
  175. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  176. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  177. Prantner D, et al. 2011. Infect Immun. 79:3922. PubMed
  178. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  179. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  180. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  181. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  182. Gao H, et al. 2021. Cells. 10:. PubMed
  183. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  184. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  185. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  186. Lv F, et al. 2022. iScience. 25:103639. PubMed
  187. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  188. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  189. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  190. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  191. Amash A, et al. 2016. J Immunol. 196: 3331-3340. PubMed
  192. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  193. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  194. Oatley J, et al. 2009. Development. 136:1191. PubMed
  195. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  196. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  197. Yu Y, et al. 2019. J Clin Invest. 129:546. PubMed
  198. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  199. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  200. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  201. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  202. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  203. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  204. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  205. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  206. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  207. Bretscher P, et al. 2015. EMBO Mol Med. 7:593. PubMed
  208. Hara-Chikuma H 2016. Mol Cell Biol. 36: 1206-1218. PubMed
  209. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  210. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  211. Chen F et al. 2018. Cell reports. 25(10):2775-2783 . PubMed
  212. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  213. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  214. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  215. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  216. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  217. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  218. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  219. Wang W, et al. 2018. Oncogenesis. 7:97. PubMed
  220. Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed
  221. Toda G, et al. 2021. STAR Protoc. 2:100246. PubMed
  222. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  223. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  224. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  225. Pfefferlé M, et al. 2021. Front Immunol. 12:680855. PubMed
  226. Wara AK, et al. 2020. Cell Rep. 33:108550. PubMed
  227. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  228. Yang Y, et al. 2022. Elife. 11:. PubMed
  229. Fairfax K, et al. 2013. J Immunol. 191:4202. PubMed
  230. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  231. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  232. Wang T, et al. 2018. Front Physiol. 9:209. PubMed
  233. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  234. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  235. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  236. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  237. Matundan H, et al. 2019. J Virol. 93. PubMed
  238. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  239. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  240. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  241. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  242. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  243. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  244. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  245. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  246. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  247. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  248. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  249. Lang V, et al. 2021. Elife. 10:. PubMed
  250. Jaggi U, et al. 2021. PLoS Pathog. 17:e1009999. PubMed
  251. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  252. Kostadinova E, et al. 2016. Sci Rep. 6:30943. PubMed
  253. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  254. Kuwahara G, et al. 2014. PLoS One. 9:106987. PubMed
  255. Patankar Y, et al. 2013. Infect Immun . 81:2043. PubMed
  256. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  257. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  258. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  259. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  260. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  261. Brown SM et al. 2017. Endocrinology. 158(10):3592-3604 . PubMed
  262. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  263. Zheng X, et al. 2018. J Clin Invest. 128:2104. PubMed
  264. Chung EJ, et al. 2022. Aging (Albany NY). 14:7692. PubMed
  265. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  266. Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
  267. Ye ZH, et al. 2021. Transl Oncol. 14:101162. PubMed
  268. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  269. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  270. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  271. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  272. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  273. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  274. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  275. Kim K, et al. 2014. Proc Natl Acad Sci U S A. 111:11774. PubMed
  276. Hu J, et al. 2015. J Hepatol. Available online 31 August 2015. PubMed
  277. Terrazas M 2014. Int J Parasit. 44 613 . PubMed
  278. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  279. Cao Q, et al. 2019. Theranostics. 5.576388889. PubMed
  280. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  281. Calle P, et al. 2021. Cells. 10:. PubMed
  282. Ishikura S, et al. 2021. J Cell Biochem. . PubMed
  283. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  284. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  285. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  286. Chen F, et al. 2022. Cell Rep. 38:110215. PubMed
  287. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  288. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  289. Chen Z, et al. 2016. Nat Commun. 7:11596. PubMed
  290. Deng W, et al. 2015. Clin Immunol. . PubMed
  291. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  292. Shaw O, et al. 2014. Rheumatology. 53:1901. PubMed
  293. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  294. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  295. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  296. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  297. Engblom C, et al. 2017. Science. 358:6367. PubMed
  298. Zhao F et al. 2018. Immunity. 48(1):147-160 . PubMed
  299. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  300. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  301. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  302. Zhang H, et al. 2017. Immunol Cell Biol. 10.1038/icb.2017.11. PubMed
  303. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  304. Kerkhofs D, et al. 2020. Theranostics. 7.022222222. PubMed
  305. Toda G, et al. 2020. Molecular Cell. 79(1):43-53.e4. PubMed
  306. Karki R, et al. 2020. bioRxiv. . PubMed
  307. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  308. Liu J, et al. 2021. Front Immunol. 12:733808. PubMed
  309. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  310. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  311. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  312. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  313. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  314. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  315. Wang X, et al. 2016. J Immunol. 197(12):4750-4761. PubMed
  316. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  317. Horsle B 2013. Development. 140:1517. PubMed
  318. Gu H, et al. 2021. Elife. 10:. PubMed
  319. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  320. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  321. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  322. Karki R, et al. 2021. Cell. 184:149. PubMed
  323. Caoa X, et al. 2017. Neurosci Lett. 10.1016/j.neulet.2017.02.045. PubMed
  324. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  325. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  326. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  327. Panagi M, et al. 2020. Theranostics. 10:1910. PubMed
  328. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  329. Jeurissen M, et al. 2016. PLoS One. 11:e0167199. PubMed
  330. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  331. Neimert-Andersson T, et al. 2011. Vaccine. 29:8965. PubMed
  332. Sun L, et al. 2009. FASEB J. 3.602777778. PubMed
  333. Esposito E, et al. 2019. Nat Commun. 4.101388889. PubMed
  334. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  335. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  336. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  337. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  338. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  339. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  340. Mirsoian A, et al. 2014. J Exp Med. 211:2373. PubMed
  341. Yin X, et al. 2015. J Immunol. 194:4029. PubMed
  342. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  343. Singh KS, et al. 2020. Nat Commun. 0.786805556. PubMed
  344. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  345. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  346. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  347. Nishino T, et al. 2018. Arterioscler Thromb Vasc Biol. 38:2460. PubMed
  348. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  349. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  350. Liu SS, et al. 2021. Immunity. :. PubMed
  351. Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed
  352. Cao H, et al. 2020. Front Pharmacol. 11:578943. PubMed
  353. Ling X, et al. 2021. Biomaterials. 270:120690. PubMed
  354. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  355. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  356. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  357. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  358. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  359. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  360. Sockolosky J, et al. 2016. Proc Natl Acad Sci U S A. 113: 2646 - 2654. PubMed
  361. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  362. Ishizuka M, et al. 2015. PLoS One. 10: 0137978. PubMed
  363. Pechous R, et al. 2015. MBio. 6:2302. PubMed
  364. Yin T, et al. 2015. J Immunol. 194:429. PubMed
  365. Klezovich-Bénard M, et al. 2012. PLoS One. 8:e1002481. PubMed
  366. Karpurapu M, et al. 2011. Blood. 118:5255. PubMed
  367. Yan K, et al. 2020. Cell Death Dis. 1.013888889. PubMed
  368. Eghbalzadeh K, et al. 2019. Front Immunol. 2.022916667. PubMed
  369. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  370. Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed
  371. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  372. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  373. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  374. Gardner A, et al. 2022. J Immunother Cancer. 10:. PubMed
  375. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  376. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  377. Collins C, et al. 2014. Proc Natl Acad Sci U S A. 111:9899. PubMed
  378. Bramwell K, et al. 2015. J Immunol. 195: 1647 - 1656. PubMed
  379. Legrain S, et al. 2015. J Immunol. 195: 4171 - 4175. PubMed
  380. Schuijs M, et al. 2016. PLoS One. 11: 016188. PubMed
  381. Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed
  382. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  383. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  384. Kim M, et al. 2012. J Immunol. 188:4158. PubMed
  385. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  386. Koupenova M, et al. 2019. iScience. 19:916. PubMed
  387. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  388. Liu ZZ, et al. 2021. Front Immunol. 12:636861. PubMed
  389. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  390. Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
  391. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  392. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  393. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  394. Chung EJ, et al. 2021. Int J Radiat Oncol Biol Phys. 110:526. PubMed
  395. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  396. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
  397. Malik M, et al. 2012. Proc Natl Acad Sci U S A. 109:6130. PubMed
  398. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  399. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  400. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  401. Sparber F et al. 2019. British journal of pharmacology. 176(11):1728-1744 . PubMed
  402. Lalor R, et al. 2019. Nutrients. 11. PubMed
RRID
AB_893493 (BioLegend Cat. No. 123115)
AB_893481 (BioLegend Cat. No. 123116)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kupffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
F4/80
Specificity Alt (DOES NOT SHOW ON TDS):
F4/80
App Abbreviation (DOES NOT SHOW ON TDS):
FC
Hidden Names (DOES NOT SHOW ON TDS):
F4, F80, Macrophage, Myeloid Dendritic Cell, Plasmacytoid Dendritic Cell
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All F4/80 Reagents Request Custom Conjugation
Description Clone Applications
Brilliant Violet 605™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 BM8 FC,IHC,WB
Biotin anti-mouse F4/80 BM8 FC,IHC
FITC anti-mouse F4/80 BM8 FC
PE anti-mouse F4/80 BM8 FC
PE/Cyanine5 anti-mouse F4/80 BM8 FC
PE/Cyanine7 anti-mouse F4/80 BM8 FC
APC anti-mouse F4/80 BM8 FC
APC/Cyanine7 anti-mouse F4/80 BM8 FC
Alexa Fluor® 488 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Alexa Fluor® 647 anti-mouse F4/80 BM8 FC,IHC-F,3D IHC
Pacific Blue™ anti-mouse F4/80 BM8 FC
PerCP anti-mouse F4/80 BM8 FC
PerCP/Cyanine5.5 anti-mouse F4/80 BM8 FC
Alexa Fluor® 700 anti-mouse F4/80 BM8 FC
Brilliant Violet 421™ anti-mouse F4/80 BM8 FC,IHC-F,SB
Brilliant Violet 510™ anti-mouse F4/80 BM8 FC
Alexa Fluor® 594 anti-mouse F4/80 BM8 IHC-F
Brilliant Violet 785™ anti-mouse F4/80 BM8 FC
Purified anti-mouse F4/80 (Maxpar® Ready) BM8 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse F4/80 BM8 FC
Brilliant Violet 650™ anti-mouse F4/80 BM8 FC
Brilliant Violet 711™ anti-mouse F4/80 BM8 FC
APC/Fire™ 750 anti-mouse F4/80 BM8 FC
TotalSeq™-A0114 anti-mouse F4/80 BM8 PG
TotalSeq™-B0114 anti-mouse F4/80 BM8 PG
TotalSeq™-C0114 anti-mouse F4/80 BM8 PG
Spark YG™ 570 anti-mouse F4/80 BM8 IHC-F
KIRAVIA Blue 520™ anti-mouse F4/80 BM8 FC
Ultra-LEAF™ Purified anti-mouse F4/80 BM8 FC,IHC,WB
APC/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark NIR™ 685 anti-mouse F4/80 BM8 FC
Spark Blue™ 550 anti-mouse F4/80 BM8 FC
Brilliant Violet 570™ anti-mouse F4/80 BM8 FC
Brilliant Violet 750™ anti-mouse F4/80 BM8 FC
PE/Fire™ 810 anti-mouse F4/80 BM8 FC
Spark Red™ 718 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
Spark Blue™ 574 anti-mouse F4/80 (Flexi-Fluor™) BM8 FC
PE/Fire™ 640 anti-mouse F4/80 BM8 FC
Go To Top Version: 2    Revision Date: 10.25.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account